Yatharth Hospital & Trauma Care Services Ltd. (YATHARTH) fundamentals
Yatharth Hospital & Trauma Care Services Ltd. is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as YATHARTH (ISIN INE0JO301016). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Yatharth Hospital & Trauma Care Services Ltd. does
Yatharth Hospital & Trauma Care Services Limited is engaged in providing healthcare services, operating hospitals and other allied services. Its facilities include amenities, guidelines for admission, visitor policy, helpdesk, empanelment’s, and preventive health checkup. It provides a spectrum of specialty services in the fields of Cardiology, Neurosciences, Pediatrics, Gastroenterology, Pulmonology, Robotic Surgery, Dermatology, Endocrinology, Dentistry, Radiology, Ophthalmology, Cancer & Bone Marrow Transplant, Nephrology & Urology, General Surgery, Psychology & Psychiatry, Plastic & Cosmetic Surgery, Vitro Fertilization (IVF) & Fertility, and Interventional Spine & Pain Medicine. It also provides Nuclear Medicine, Pathology & Laboratory Medicine, Nutrition & Health, Physiotherapy & Rehab, Emergency Medicine, and more. It has hospitals in Greater Noida, Noida, Noida Extension, Jhansi Orchha, and Faridabad. It also has a super-specialty hospital located in Model Town, New Delhi.
Valuation and market data
| Last close | ₹925.00 |
|---|---|
| Market capitalisation | ₹8,656 crore |
| Enterprise value | ₹8,726 crore |
| P/E (TTM) | 50.82 |
| Price to book | 4.79 |
| Price to sales (TTM) | 3.90 |
| Book value per share | ₹193.12 |
| Dividend yield | 5.41% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Mon Aug 07 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹615 crore | ₹127 crore | ₹95 crore | 9.90 |
| Mar 2025 | ₹466 crore | ₹119 crore | ₹88 crore | 9.89 |
| Mar 2024 | ₹433 crore | ₹113 crore | ₹84 crore | 10.61 |
| Mar 2023 | ₹373 crore | ₹86 crore | ₹64 crore | 9.83 |
| Mar 2022 | ₹300 crore | ₹60 crore | ₹42 crore | 6.46 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Sep 2026:
| Promoters | 55.8% |
|---|---|
| Foreign institutions (FII) | 7.0% |
| Mutual funds | 9.6% |
| Other domestic institutions | 1.4% |
| Retail and others | 26.2% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.